These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 29217474)
21. PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release. Faisant N; Siepmann J; Benoit JP Eur J Pharm Sci; 2002 May; 15(4):355-66. PubMed ID: 11988397 [TBL] [Abstract][Full Text] [Related]
22. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles. Zhao A; Rodgers VG J Control Release; 2006 Jun; 113(1):15-22. PubMed ID: 16707186 [TBL] [Abstract][Full Text] [Related]
23. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory. Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257 [TBL] [Abstract][Full Text] [Related]
24. Ramizol Wright L; Rao S; Thomas N; Boulos RA; Prestidge CA Drug Dev Ind Pharm; 2018 Sep; 44(9):1451-1457. PubMed ID: 29619851 [TBL] [Abstract][Full Text] [Related]
25. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery. Díez S; Tros de Ilarduya C Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172 [TBL] [Abstract][Full Text] [Related]
26. In vitro evaluation of suspoemulsions for in situ-forming polymeric microspheres and controlled release of progesterone. Turino LN; Mariano RN; Mengatto LN; Luna JA J Microencapsul; 2015; 32(6):538-46. PubMed ID: 26218541 [TBL] [Abstract][Full Text] [Related]
27. Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres. Xu FH; Zhang Q Yao Xue Xue Bao; 2007 Jan; 42(1):1-7. PubMed ID: 17520799 [TBL] [Abstract][Full Text] [Related]
28. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds. Hu Y; Hollinger JO; Marra KG J Drug Target; 2001; 9(6):431-8. PubMed ID: 11822815 [TBL] [Abstract][Full Text] [Related]
29. Combination of injectable ethinyl estradiol and drospirenone drug-delivery systems and characterization of their in vitro release. Nippe S; General S Eur J Pharm Sci; 2012 Nov; 47(4):790-800. PubMed ID: 22940138 [TBL] [Abstract][Full Text] [Related]
30. Formation Mechanism and In Vitro Evaluation of Risperidone-Containing PLGA Microspheres Fabricated by Ultrafine Particle Processing System. Huang Z; Chen X; Fu H; Wen X; Ma C; Zhang J; Wu C; Huang Y; Pan X; Wu C J Pharm Sci; 2017 Nov; 106(11):3363-3371. PubMed ID: 28736289 [TBL] [Abstract][Full Text] [Related]
31. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model. Ayalasomayajula SP; Kompella UB Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788 [TBL] [Abstract][Full Text] [Related]
32. [Preparation of alginate-chitosan-poly (lactic-co-glycolic acid) composite microsphere and its regulation of protein release]. Zheng CH; Liang WQ; Yu HY Yao Xue Xue Bao; 2005 Feb; 40(2):182-6. PubMed ID: 15875679 [TBL] [Abstract][Full Text] [Related]
33. Osmogen-Mediated One-Step Technique of Fabricating Hollow Microparticles for Encapsulation and Delivery of Bioactive Molecules. Kharel S; Lee WL; Lee XY; Loo SC Macromol Biosci; 2017 Apr; 17(4):. PubMed ID: 27860265 [TBL] [Abstract][Full Text] [Related]
34. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique. Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445 [TBL] [Abstract][Full Text] [Related]
36. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis. Duvvuri S; Janoria KG; Pal D; Mitra AK J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010 [TBL] [Abstract][Full Text] [Related]
37. Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology. Emami J; Hamishehkar H; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Mirzadeh H; Fakhari A; Nokhodchi A J Microencapsul; 2009 Feb; 26(1):1-8. PubMed ID: 18465287 [TBL] [Abstract][Full Text] [Related]
38. Preparation and characterization of poly(D,L-lactic-co-glycolic Acid) microspheres containing flurbiprofen sodium. Samati Y; Yüksel N; Tarimci N Drug Deliv; 2006; 13(2):105-11. PubMed ID: 16423798 [TBL] [Abstract][Full Text] [Related]
39. Donepezil accelerates the release of PLGA microparticles via catalyzing the polymer degradation regardless of the end groups and molecular weights. Quan P; Guo W; LinYang ; Cun D; Yang M Int J Pharm; 2023 Feb; 632():122566. PubMed ID: 36586633 [TBL] [Abstract][Full Text] [Related]
40. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. Jackson JK; Hung T; Letchford K; Burt HM Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]